PortfoliosLab logoPortfoliosLab logo
MUSA vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MUSA vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Murphy USA Inc. (MUSA) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MUSA achieves a 32.98% return, which is significantly higher than LLY's 14.83% return. Over the past 10 years, MUSA has underperformed LLY with an annualized return of 22.11%, while LLY has yielded a comparatively higher 33.74% annualized return.


MUSA

1D
1.67%
1M
5.75%
YTD
32.98%
6M
31.96%
1Y
31.97%
3Y*
20.39%
5Y*
32.71%
10Y*
22.11%

LLY

1D
1.81%
1M
11.31%
YTD
14.83%
6M
14.40%
1Y
59.73%
3Y*
38.89%
5Y*
41.22%
10Y*
33.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MUSA vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MUSA
Murphy USA Inc.
32.98%-19.15%41.27%28.20%41.02%53.33%12.06%52.66%-4.63%30.73%
LLY
Eli Lilly and Company
14.83%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between MUSA and LLY is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.02

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Aug 19, 2013

0.15

The correlation between MUSA and LLY shifts across timeframes, from -0.02 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MUSA:

$10.01B

LLY:

$1.10T

EPS

MUSA:

$29.26

LLY:

$28.16

PE Ratio

MUSA:

18.29

LLY:

43.68

PEG Ratio

MUSA:

0.99

LLY:

0.88

PS Ratio

MUSA:

0.51

LLY:

15.28

PB Ratio

MUSA:

15.20

LLY:

35.32

Total Revenue (TTM)

MUSA:

$19.68B

LLY:

$72.25B

Gross Profit (TTM)

MUSA:

$487.10M

LLY:

$59.75B

EBITDA (TTM)

MUSA:

$1.06B

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MUSA vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MUSA
MUSA Risk / Return Rank: 6969
Overall Rank
MUSA Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
MUSA Sortino Ratio Rank: 6464
Sortino Ratio Rank
MUSA Omega Ratio Rank: 6666
Omega Ratio Rank
MUSA Calmar Ratio Rank: 7373
Calmar Ratio Rank
MUSA Martin Ratio Rank: 7070
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 8282
Overall Rank
LLY Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 8080
Sortino Ratio Rank
LLY Omega Ratio Rank: 8282
Omega Ratio Rank
LLY Calmar Ratio Rank: 8282
Calmar Ratio Rank
LLY Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MUSA vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Murphy USA Inc. (MUSA) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MUSALLYDifference
Sharpe ratioReturn per unit of total volatility

-0.75

Sortino ratioReturn per unit of downside risk

-0.86

Omega ratioGain probability vs. loss probability

1.18

1.30

-0.11

Calmar ratioReturn relative to maximum drawdown

1.63

2.59

-0.96

Martin ratioReturn relative to average drawdown

3.25

6.47

-3.22

MUSA vs. LLY - Sharpe Ratio Comparison

The current MUSA Sharpe Ratio is 0.82, which is lower than the LLY Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of MUSA and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MUSA vs. LLY - Drawdown Comparison

The maximum MUSA drawdown since its inception was -35.54%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for MUSA and LLY.


Loading charts...

Drawdown Indicators


MUSALLYDifference

Max Drawdown

Largest peak-to-trough decline

-35.54%

-68.24%

+32.70%

Max Drawdown (1Y)

Largest decline over 1 year

-19.72%

-23.18%

+3.46%

Max Drawdown (3Y)

Largest decline over 3 years

-35.54%

-34.48%

-1.06%

Max Drawdown (5Y)

Largest decline over 5 years

-35.54%

-34.48%

-1.06%

Max Drawdown (10Y)

Largest decline over 10 years

-35.54%

-34.48%

-1.06%

Current Drawdown

Current decline from peak

-14.04%

0.00%

-14.04%

Average Drawdown

Average peak-to-trough decline

-9.98%

-19.20%

+9.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.85%

9.26%

+0.59%

Volatility

MUSA vs. LLY - Volatility Comparison

Murphy USA Inc. (MUSA) has a higher volatility of 14.17% compared to Eli Lilly and Company (LLY) at 10.06%. This indicates that MUSA's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MUSALLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.17%

10.06%

+4.11%

Volatility (6M)

Calculated over the trailing 6-month period

31.34%

27.75%

+3.59%

Volatility (1Y)

Calculated over the trailing 1-year period

39.34%

38.44%

+0.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.64%

32.44%

-1.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.45%

30.26%

+1.19%

Dividends

MUSA vs. LLY - Dividend Comparison

MUSA's dividend yield for the trailing twelve months is around 0.45%, less than LLY's 0.53% yield.


PositionTTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.53%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
MUSA
Murphy USA Inc.
0.45%0.53%0.36%0.43%0.45%0.52%0.19%0.00%0.00%0.00%0.00%0.00%

Financials

MUSA vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Murphy USA Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
4.82B
19.80B
(MUSA) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

MUSA vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Murphy USA Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
79.0%
Portfolio components
MUSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Murphy USA Inc. reported a gross profit of 0.00 and revenue of 4.82B. Therefore, the gross margin over that period was 0.0%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

MUSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Murphy USA Inc. reported an operating income of 205.20M and revenue of 4.82B, resulting in an operating margin of 4.3%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

MUSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Murphy USA Inc. reported a net income of 136.30M and revenue of 4.82B, resulting in a net margin of 2.8%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


MUSA and LLY have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MUSA has higher volatility (14.17%) compared to LLY (10.06%). In terms of maximum drawdown, MUSA dropped -35.54% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.56 vs 0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MUSA and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer